Rinvoq (upadacitinib)

Product Name:

Rinvoq (upadacitinib)

Categories: Dermatology, Gastroenterology, Immunology, Rheumatology

Discover Savings on Your Medication Access

Trusted concierge service, secure process, and real savings for patients in the U.S.

Table of Contents

Rinvoq (upadacitinib)

Product Category

Immunology / Rheumatology / Dermatology / Gastroenterology

Brand Name

Rinvoq

Generic Name or Biosimilar

No generic or biosimilar available

Active Ingredient

Upadacitinib

Prescription Status

Prescription-only (oral small molecule)

Targeted Conditions

  • Moderate-to-severe rheumatoid arthritis (RA) in adults
  • Active psoriatic arthritis (PsA) in adults
  • Active ankylosing spondylitis (AS) in adults
  • Non-radiographic axial spondyloarthritis in adults
  • Moderate-to-severe atopic dermatitis (eczema) in adults and children ≥12 years
  • Moderate-to-severe ulcerative colitis in adults
  • Moderate-to-severe Crohn’s disease in adults

Off-Label Usage

  • Other autoimmune diseases under investigation (e.g., lupus, giant cell arteritis, alopecia areata)

(Off-label usage should be guided by a specialist and is not formally approved by FDA, Health Canada, or COFEPRIS.)

Drug Classification Overview

Rinvoq is a selective Janus kinase (JAK) inhibitor.
It blocks JAK1 signaling, reducing the activity of inflammatory cytokines involved in autoimmune and inflammatory conditions.

Manufacturer in the USA, Mexico, and Canada

USA: AbbVie Inc.
Mexico: AbbVie México, S.A. de C.V.
Canada: AbbVie Corporation

Available Strengths and Dosage Forms – United States, Mexico, and Canada

Country Comparison – United States vs Mexico and Canada

  • Equivalent oral formulation across all three countries
  • Packaging and labeling may vary
  • No cold chain required (oral tablet)

Average Retail Price (Monthly Treatment)

Canada: Approximate savings of 35–55% vs U.S. retail
Mexico: Approximate savings of 30–50% vs U.S. retail

Savings vary depending on local regulations, pharmacy access, and insurance coverage.

Where to Buy USA

  • Available at major U.S. retail and specialty pharmacies: CVS, Walgreens, Walmart, Costco, Rite Aid, Kroger, Albertsons, Sam’s Club, Publix, Target (via CVS Pharmacy), and specialty mail-order pharmacies

Insurance coverage and prior authorization may be required.

Storage Requirements

  • Store at room temperature (20°C–25°C / 68°F–77°F)
  • Protect from moisture and sunlight

Key Benefits

  • Oral tablet – convenient non-injectable option
  • Reduces symptoms and improves physical function in arthritis and spondyloarthritis
  • Improves skin clearance in atopic dermatitis
  • Induces and maintains remission in ulcerative colitis and Crohn’s disease
  • Rapid onset compared to some biologics

Shipping from Canada

Rinvoq is accessed through licensed Canadian pharmacies regulated by Health Canada. MedicalMex coordinates access through certified specialty pharmacies and treatment centers.

MedicalMex facilitates:

  • Prescription verification and coordination
  • Telehealth consultations with licensed specialists if required
  • Insurance and payment support
  • Case management and bilingual patient support

Buying from Mexico

Rinvoq is available through certified pharmacies in Mexico regulated by COFEPRIS. MedicalMex facilitates patient access through licensed treatment centers.

MedicalMex facilitates:

  • Prescription handling with licensed physicians
  • Telehealth consultations if needed
  • Travel coordination if in-person access is required
  • Concierge bilingual patient support

Side Effects

  • Common: Upper respiratory tract infections; Nausea; Cough; Fever
  • Moderate: Hypertension; Elevated liver enzymes; Anemia
  • Serious: Serious infections; Malignancies; Thrombosis; Cardiovascular events

Patients must be monitored for infection risk, cardiovascular complications, and lab abnormalities during therapy.

Warnings and Precautions

  • Screen for tuberculosis and viral hepatitis before treatment
  • Avoid live vaccines during therapy
  • Monitor CBC, liver enzymes, and lipids periodically
  • Caution in patients with history of malignancy, thromboembolism, or cardiovascular disease
  • Pregnancy and breastfeeding: safety not fully established

Alternative Medications (by Indication)

Other JAK inhibitors: Tofacitinib (Xeljanz), Baricitinib (Olumiant), Filgotinib (Jyseleca)
Biologics: Adalimumab (Humira), Ustekinumab (Stelara), Secukinumab (Cosentyx), Dupilumab (Dupixent)
Traditional DMARDs: Methotrexate, Azathioprine, Cyclosporine

Medication FAQs

Rinvoq is prescribed for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, ulcerative colitis, and Crohn’s disease.

It is taken orally as a tablet once daily, with or without food.

Yes. Regular monitoring of blood counts, liver enzymes, and cholesterol levels is required.

No. It is a small molecule JAK inhibitor, not a monoclonal antibody biologic.

Some patients experience improvement within 2–4 weeks, with continued benefit over months of therapy.

Yes. Rinvoq is a prescription-only medication and must be prescribed by a licensed specialist.

It may be combined with methotrexate or other non-biologic DMARDs but should not be combined with other JAK inhibitors or biologics.

Yes. MedicalMex facilitates access through licensed pharmacies and treatment centers in both countries.

Yes. Since it is an oral tablet, no cold chain is required, but keep it in original packaging.

Concierge services including prescription validation, Telehealth consultations, logistics, insurance navigation, and bilingual patient support.